| 1 |
34756920 | Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells. | 2022 Feb |
1 |
| 2 |
34952353 | The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD. | 2022 |
1 |
| 3 |
34983657 | Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro. | 2022 Jan 4 |
1 |
| 4 |
33070154 | The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study. | 2021 Apr |
1 |
| 5 |
33460184 | Association of the Fatty Acid Amide Hydrolase C385A Polymorphism With Alcohol Use Severity and Coping Motives in Heavy-Drinking Youth. | 2021 Mar |
1 |
| 6 |
34827417 | The Inhibition of the Degrading Enzyme Fatty Acid Amide Hydrolase Alters the Activity of the Cone System in the Vervet Monkey Retina. | 2021 Oct 27 |
2 |
| 7 |
34959715 | Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review. | 2021 Dec 17 |
1 |
| 8 |
31914367 | HYPNOTIZABILITY-RELATED FAAH C385A POLYMORPHISM: POSSIBLE ENDOCANNABINOID CONTRIBUTION TO SUGGESTION-INDUCED ANALGESIA. | 2020 Jan-Mar |
1 |
| 9 |
32041998 | The endocannabinoid hydrolase FAAH is an allosteric enzyme. | 2020 Feb 10 |
1 |
| 10 |
32292082 | Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? | 2020 Jul |
2 |
| 11 |
32732136 | Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity. | 2020 Nov |
1 |
| 12 |
30739035 | Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. | 2019 Apr |
1 |
| 13 |
30929760 | Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. | 2019 Aug |
2 |
| 14 |
31117309 | Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands. | 2019 May 21 |
2 |
| 15 |
31921630 | Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma. | 2019 |
1 |
| 16 |
26774927 | Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies. | 2016 Feb 15 |
1 |
| 17 |
26901181 | Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase. | 2016 Feb 18 |
2 |
| 18 |
27309570 | Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents. | 2016 Jul 14 |
1 |
| 19 |
27790143 | A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs). | 2016 |
1 |
| 20 |
27806235 | Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase. | 2016 Nov 3 |
1 |
| 21 |
24593280 | The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes. | 2014 Mar 4 |
1 |
| 22 |
24705380 | Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. | 2014 |
1 |
| 23 |
23344792 | The interaction of fatty acid amide hydrolase (FAAH) inhibitors with an anandamide carrier protein using (19)F-NMR. | 2013 Apr |
1 |
| 24 |
23488865 | Latest advances in the discovery of fatty acid amide hydrolase inhibitors. | 2013 May |
2 |
| 25 |
26588763 | Wagging the Tail: Essential Role of Substrate Flexibility in FAAH Catalysis. | 2013 Feb 12 |
1 |
| 26 |
22473870 | Contribution of genetic variants to pain susceptibility in Parkinson disease. | 2012 Oct |
1 |
| 27 |
21477106 | Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. | 2011 Jul |
1 |
| 28 |
20022504 | Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. | 2010 Feb 1 |
1 |
| 29 |
20152858 | N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). | 2010 Oct |
1 |
| 30 |
18289091 | Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors. | 2008 |
2 |
| 31 |
18753625 | Structure-guided inhibitor design for human FAAH by interspecies active site conversion. | 2008 Sep 2 |
1 |
| 32 |
18851692 | The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | 2008 Nov |
1 |
| 33 |
17158103 | Closing the gate to the active site: effect of the inhibitor methoxyarachidonyl fluorophosphonate on the conformation and membrane binding of fatty acid amide hydrolase. | 2007 Feb 9 |
1 |
| 34 |
16392827 | Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates. | 2006 Jan 12 |
1 |
| 35 |
16892344 | Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring. | 2006 Jan |
1 |
| 36 |
17015445 | A second fatty acid amide hydrolase with variable distribution among placental mammals. | 2006 Dec 1 |
1 |
| 37 |
15533037 | Assignment of endogenous substrates to enzymes by global metabolite profiling. | 2004 Nov 16 |
1 |
| 38 |
23409303 | 6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[11C-carbonyl]carbamate | 2004 |
1 |
| 39 |
11585048 | Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. | 2001 Sep 1 |
1 |